Assembly Biosciences (ASMB) Preferred Shares (2013)
Assembly Biosciences (ASMB) recorded quarterly Preferred Shares of $44.0 in Q4 2013, down 80.0% quarter-over-quarter from $220.0 in Q3 2013.
Assembly Biosciences (ASMB) Preferred Shares (2013) Analysis & Trends
Assembly Biosciences' Preferred Shares history runs 1 years deep, the most recent figure standing at $44.0 for Q4 2013.
- In Q4 2013, Preferred Shares changed N/A year-over-year to $44.0; the TTM figure through Dec 2013 stood at $44.0 (changed N/A YoY), while the FY2013 annual figure was $44.0, changed N/A from the prior year.
- Preferred Shares was $44.0 for Q4 2013 at Assembly Biosciences, down from $220.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $220.0 in Q1 2013 to a low of $44.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 44.00 |
| Sep 30, 2013 | 220.00 |
| Jun 30, 2013 | 220.00 |
| Mar 31, 2013 | 220.00 |